Provided by Tiger Fintech (Singapore) Pte. Ltd.

Altimmune, Inc.

5.62
+0.16002.93%
Post-market: 5.650.0300+0.53%19:59 EDT
Volume:3.88M
Turnover:22.01M
Market Cap:455.82M
PE:-4.50
High:5.81
Open:5.48
Low:5.47
Close:5.46
Loading ...
Sep 24, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Sep 24, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Aug 31, 2021

Beneficial Ownership Change

Altimmune, Inc.
Aug 31, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Aug 10, 2021

Major Issues Report

8-K - Current report
Aug 10, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 29, 2021

Major Issues Report

8-K - Current report
Jun 16, 2021

Major Issues Report

8-K - Current report
May 17, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 17, 2021

Major Issues Report

8-K - Current report
Apr 01, 2021

Major Issues Report

8-K - Current report
Mar 12, 2021

Major Issues Report

8-K - Current report
Mar 01, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 25, 2021

Major Issues Report

8-K - Current report
Feb 25, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 25, 2021

Major Issues Report

8-K - Current report
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 08, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals